Contents
Current Drug Targets - Inflammation & Allergy, Volume 4 - Number 5
Perinatal Events Affecting the Onset of Allergic Diseases
, 4(5): 523 - 529Udo Herz and Bryon Petschow
DOI: 10.2174/156801005774322144
Skin Barrier Dysfunction and Systemic Sensitization to Allergens Through the Skin
, 4(5): 531 - 541Jessica Strid and Stephan Strobel
DOI: 10.2174/156801005774322199
Pharmaceutical Treatment of Asthma in Children
, 4(5): 543 - 549Kai-Hakon Carlsen
DOI: 10.2174/156801005774322216
Anti-IgE Therapy in Allergic Asthma
, 4(5): 551 - 564Claudia Rolinck-Werninghaus, Ulrich Wahn and Eckard Hamelmann
DOI: 10.2174/156801005774322162
Mucosal Immunoregulation: Transcription Factors as Possible Therapeutic Targets
, 4(5): 565 - 575Aysefa Doganci, Markus F. Neurath and Susetta Finotto
DOI: 10.2174/156801005774322153
Design of Protective and Therapeutic DNA Vaccines for the Treatment of Allergic Diseases
, 4(5): 585 - 597Richard Weiss, Peter Hammerl, Arnulf Hartl, Romana Hochreiter, Wolfgang W. Leitner, Sandra Scheiblhofer and Josef Thalhamer
DOI: 10.2174/156801005774322171
Evidence of Probiotics in Prevention of Allergy and Asthma
, 4(5): 599 - 604Bengt Bjorksten
DOI: 10.2174/156801005774322135
Webmaster Contact: info@benthamscience.org